What's Next When Treatment for Triple-Negative Breast Cancer Stops Working?

Treatment for triple-negative breast cancer has advanced significantly, but challenges remain when, in some cases, the disease returns after treatment.

In this episode, we sit down with Dr Belinda Yeo to explore treatment options for triple-negative breast cancer patientswhose cancer has that has relapsed.

Dr Yeo discusses the challenges clinicians face when deciding what treatment to offer next, emerging therapies showingpromise, and the critical role that clinical trials continue to play in improving outcomes for people with triple-negative breast cancer.

(3:03) If a patient's cancer does return after these therapies, what are clinicians' biggest challenges in determining what treatment to offer next?
(04:21) As a clinician, what treatment approaches or emerging therapies for triple-negative breast cancer are giving you the most optimism?
(06:05) How important is participation in clinical trials?
(07:21) What is one key message that you'd like patients navigating triple-negative breast cancer to take away from this episode?

Tune in for a deep dive into this important research.

Like this episode? ⁠⁠

Follow Breast Cancer Trials on Social Media:

Instagram:⁠ @breastcancertrials
Facebook:⁠ ⁠Breast Cancer Trials
LinkedIn: Breast Cancer Trials
X: ⁠⁠@BCTrialsANZ

Guest: Medical Oncologist, Dr Belinda Yeo.

Thank you for listening! If you found this episode valuable, please share it with your loved ones and help spread awareness about the importance of clinical trials research.

Det här avsnittet är hämtat från ett öppet RSS-flöde och publiceras inte av Podme. Det kan innehålla reklam.

Avsnitt(167)

Hot Flushes, Poor Sleep & More: Managing Menopause After Breast Cancer

Breast cancer treatment can bring on menopause suddenly or make existing symptoms more severe, significantly affecting a woman's quality of life. In this episode, we sit down with Dr Christina Jang to...

30 Sep 7min

What Makes Lobular Breast Cancer Different? Unlocking the Biology of Invasive Lobular Carcinoma

Invasive lobular carcinoma is the second most common type of breast cancer, yet there is still much to learn about what makes this disease biologically distinct. In this episode, we sit down with Asso...

8 Sep 5min

Could Patients with Breast Cancer Safely Skip Radiation & the Potential Side Effects? Inside the ROSALIE Clinical Trial

Could Patients with Breast Cancer Safely Skip Radiation & the Potential Side Effects? Inside the ROSALIE Clinical TrialCould skipping radiation after breast-conserving surgery be safe for some patient...

6 Feb 6min

Neoadjuvant Now: What's Next in Pre-Surgical Breast Cancer Treatment?

Neoadjuvant Now: What's Next in Pre-Surgical Breast Cancer Treatment?More and more breast cancer patients are now receiving treatment before surgery - but what’s next for this approach? In this episod...

7 Nov 20259min

Next Gen Oncology: Insights for Trainees and Early-Career Clinicians

Next Gen Oncology: Insights for Trainees and Early-Career CliniciansAre you a trainee or early career professional in oncology looking to connect, learn, and grow? In this episode, we highlight the Tr...

6 Nov 20258min

Caring for the Caregivers: Preventing Burnout in Oncology

Caring for the Caregivers: Preventing Burnout in OncologyWhat happens when the people caring for everyone else are running on empty? In this episode, we sit down with London-based Professor of psycho-...

6 Nov 202521min

Intimacy and Insight: Sexual Health After Breast Cancer

Intimacy and Insight: Sexual Health After Breast CancerSexual health after breast cancer is a topic too often left in the shadows - yet it profoundly affects quality of life both during and post-diagn...

29 Okt 202510min